BMY | tickerfilter.com

Fundamental analysis

71%

Profitability 73%

Dept financing 40%

Liquidity 59%

Performance 79%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

3.60%

1 Month

3.55%

3 Months

10.97%

6 Months

38.04%

1 Year

22.95%

2 Year

22.97%

Key data

Stock price

$60.17

P/E Ratio

15.38

DAY RANGE

$58.54 - $60.48

EPS

$3.47

52 WEEK RANGE

$42.52 - $62.89

52 WEEK CHANGE

$22.95

MARKET CAP

108.526 B

YIELD

4.65%

SHARES OUTSTANDING

2.036 B

DIVIDEND

$0.63

EX-DIVIDEND DATE

04-02-2026

NEXT EARNINGS DATE

07-25-2025

BETA

-0.11

PUBLIC FLOAT

AVERAGE 10 VOLUME

$8,747,542

AVERAGE 30 VOLUME

$12,816,316

Company detail

CEO: Giovanni Caforio
Region: US
Website: bms.com
Employees: 34,300
IPO year: 1972

Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma.

BMY - BRISTOL MYERS SQUIBB CO